Tisztelt Olvasóink!
Ezúton szeretnénk figyelmükbe ajánlani a HS Talks - Biomedical & Life Sciences Collection legújabb online szemináriumait.
Az adatbázis következő témájú előadásokkal bővült: COVID-19 clinical trial, vaccines, Nanotechnologies, plasma therapy, INFβ therapy, antibody therapy, nanostructured interfaces, immunoglobulins.
Remdesivir COVID-19 clinical trial
Prof. Mahesh Parmar University College London, UK
The development of SARS-CoV-2 vaccines
Prof. Peter Hotez Baylor College of Medicine, USA
Nanotechnologies in the fight against coronaviruses
Prof. Sabine Szunerits University of Lille, France
Convalescent plasma therapy as a treatment for COVID-19
Dr. Manu Shankar-Hari NIHR Clinician Scientist & Consultant in ICM, Guy's and St Thomas' NHS Foundation Trust., UK
INFβ therapy for COVID-19: the new SNG001 drug
Prof. Stephen Holgate University of Southampton, UK
The immunogenicity problem in antibody therapy
Prof. Herman Waldmann University of Oxford, UK
Successes and failures with vaccines
Prof. Stanley Plotkin University of Pennsylvania, USA
The immune system response to the SARS-CoV-2 virus: an update
Prof. Paul Klenerman University of Oxford, UK
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA
Implementation of adaptive methods in early phase clinical trials
Prof. Gina Petroni University of Virginia, USA
Inorganic nanostructured interfaces for therapeutic delivery
Prof. Tejal Desai University of California, San Francisco, USA
Vaccine delivery
Prof. Sevda Şenel Hacettepe University, Turkey
Intravenous immunoglobulins: clinical evidence
Prof. Shaye Kivity Sheba Medical Center, Israel
Strategies for exiting the lockdown
Prof. David McCoy Queen Mary University of London, UK
INFβ therapy for COVID-19: the new SNG001 drug
Prof. Stephen Holgate University of Southampton, UK
SARS-CoV-2 human monoclonal antibody therapy
Prof. James Crowe Vanderbilt Vaccine Center, USA
The COVID-19 coronavirus outbreak: May 2020 update
Prof. Jonathan Temte University of Wisconsin, USA
Antiviral drugs (non-HIV)
Prof. Megan Shaw Mount Sinai, USA
The type I interferon system and viruses
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA
The immunogenicity problem in antibody therapy
Prof. Herman Waldmann University of Oxford, UK
Antibody engineering: beginnings to bispecifics and beyond
Dr. Ian Wilkinson Absolute Antibody, UK
Phage display for generating monoclonal antibodies
Dr. Andre Frenzel YUMAB GMBH, Germany
Usage of vaccines and therapeutics in public health emergencies 1
Prof. Gary Kobinger Laval University, Canada
The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
COVID-19 epidemiology and potential treatments: follow up interview - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Principles of virology
Prof. Vincent Racaniello Columbia University, USA
Immune responses to viruses
Prof. Paul Klenerman University of Oxford, UK
Fundamentals of HIV biology
Prof. Viviana Simon Icahn School of Medicine at Mount Sinai, USA
Cytomegalovirus biology
Prof. Domenico Tortorella Icahn School of Medicine at Mount Sinai, USA
Binding kinetics in drug discovery
Dr. Rumin Zhang VP of Discovery, Rafael Pharmaceuticals, USA
Subarachnoid hemorrhage (SAH)
Prof. R. Loch Macdonald University of San Francisco, USA
Treating diabetes in the elderly: overcoming challenges
Dr. David Strain University of Exeter Medical School, UK
Ethnic variation in the susceptibility to diabetes
Prof. Jonathan Shaw Baker IDI Heart and Diabetes Institute, Australia
Disorders of gastric function: gastroparesis and functional dyspepsia 1
Dr. Braden Kuo Harvard Medical School, USA
Disorders of gastric function: gastroparesis and functional dyspepsia 2
Dr. Braden Kuo Harvard Medical School, USA
Pediatric stroke: cerebrovascular injury in the developing brain
Prof. Adam Kirton University of Calgary, Canada
Prevention: carotid endarterectomy, angioplasty, and stenting
Prof. Brian Hoh University of Florida, USA
Measles
Prof. Diane E. Griffin Johns Hopkins Bloomberg School of Public Health, USA
Chagas disease
Prof. Peter Hotez Baylor College of Medicine, USA
The immune system response to the SARS-COV-2 virus: an update
Prof. Paul Klenerman University of Oxford, UK
Development of an intranasal vaccine for SARS-CoV-2
Dr. Scot Roberts CSO, Altimmune, USA
Development of PRO-140 (Leronlimab) as a treatment for COVID-19
Dr. Jacob Lalezari Quest Clinical Research, USA
COVID-19 epidemiology and potential treatments: follow up interview
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
COVID-19 epidemiology and potential treatments: follow up interview - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Development of PRO-140 (Leronlimab) as a treatment for COVID-19 - (open access)
Dr. Jacob Lalezari Quest Clinical Research, USA
The impact of genomic architecture and diversity on infectious diseases
Prof. Vincent Chow National University of Singapore, Singapore
Antiviral drugs (non-HIV)
Prof. Megan Shaw Mount Sinai, USA
Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA
The type I interferon system and viruses
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA
HIV cure: harnessing innate and adaptive strategies
Prof. Luis Montaner The Wistar Institute, USA
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
The COVID-19 outbreak: an update on the SARS-CoV-2 virus - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV-2 vaccine development - (open access)
Prof. Stanley Plotkin University of Pennsylvania, USA
SARS-COV-2: What we need to know and possible future therapies - (open access)
Prof. Stanley Perlman University of Iowa, USA
SARS-COV-2: What we need to know and possible future therapies - (open access)
Prof. Stanley Perlman University of Iowa, USA
SARS-COV-2 vaccine development: where are we now? - (open access)
Prof. Gary Kobinger Laval University, Canada
The current understanding of the biology of the SARS-COV-2 virus - (open access)
Prof. Peter Palese Mount Sinai School of Medicine, USA
SARS-COV-2 vaccine: current biological targets and considerations - (open access)
Dr. Adolfo Garcia-Sastre Icahn School of Medicine at Mount Sinai, USA
The paediatric response to the SARS-COV-2 virus and what we can learn from it - (open access)
Prof. Sallie Permar Duke University Medical School, USA
The COVID-19 coronavirus outbreak: a follow-up interview - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV-2 vaccine development - (open access)
Prof. Stanley Plotkin University of Pennsylvania, USA
The immune system response to the SARS-COV-2 virus - (open access)
Prof. Paul Klenerman University of Oxford, UK
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide
Dr. Marietjie Venter NICD, South Africa
Usage of vaccines and therapeutics in public health emergencies 1
Prof. Gary Kobinger Laval University, Canada
Novel approaches to diagnosis of viral infections
Prof. W. Ian Lipkin Columbia University, USA
Mitochondrial diseases: an update
Dr. Ayesha Saleem University of Manitoba, Canada
The mast cells: the mastermind cells of the allergic inflammatory reaction
Prof. Adrian Piliponsky University of Washington, USA
Eosinophil functions in allergic diseases: an evolving paradigm
Prof. Lisa A. Spencer University of Colorado School of Medicine, USA
The role of basophils in allergy
Prof. Franco H. Falcone Justus Liebig University Giessen, Germany
An introduction to autism and the autism spectrum
Prof. Fred Volkmar Yale University School of Medicine, USA
The epidemiology of autism spectrum disorders: history and current estimates
Prof. Eric Fombonne Oregon Health and Science University, USA
The epidemiology of autism spectrum disorders: time trends and world perspectives
Prof. Eric Fombonne Oregon Health and Science University, USA
Assessment and diagnosis of individuals with Autism Spectrum Disorder (ASD)
Dr. Julie M. Wolf Yale Child Study Center, USA
Plant-soil feedbacks
Dr. Ciska Veen Netherlands Institute of Ecology, Netherlands
Cholesterol oxidation between health and disease
Prof. Giuseppe Poli University of Torino, Italy
Tropical snakebite
Prof. Robert Harrison Liverpool School of Tropical Medicine, UK
Innovative and effective subject randomization methods
Prof. Wenle Zhao Medical University of South Carolina, USA
The COVID-19 outbreak: an update on the SARS-CoV-2 virus
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
The immune system response to the SARS-COV-2 virus
Prof. Paul Klenerman University of Oxford, UK
The current understanding of the biology of the SARS-COV-2 virus
Prof. Peter Palese Mount Sinai School of Medicine, USA
The paediatric response to the SARS-COV-2 virus and what we can learn from it
Prof. Sallie Permar Duke University Medical School, USA
The COVID-19 coronavirus outbreak: a follow-up interview
Prof. Jonathan Temte University of Wisconsin, USA
The COVID-19 coronavirus outbreak: a current view
Prof. Jonathan Temte University of Wisconsin, USA
The immune system response to the SARS-COV-2 virus
Prof. Paul Klenerman University of Oxford, UK
The immune system: an overview - innate immunity
Prof. Shiv Pillai Harvard Medical School, USA
The immune system: an overview - adaptive immunity
Prof. Shiv Pillai Harvard Medical School, USA
The complement system - an introduction for undergraduates
Prof. Michael Holers University of Colorado School of Medicine, USA
Vaccine delivery
Prof. Sevda Şenel Hacettepe University, Turkey
Biodefense challenges
Dr. David Franz US Army (Retired) and Kansas State University., USA
History of vaccines
Prof. Stanley Plotkin University of Pennsylvania, USA
Successes and failures with vaccines
Prof. Stanley Plotkin University of Pennsylvania, USA
The COVID-19 outbreak: an update on the SARS-CoV-2 virus - (open access)
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Vaccine delivery
Prof. Sevda Şenel Hacettepe University, Turkey
The COVID-19 coronavirus outbreak: a current view - (open access)
Prof. Jonathan Temte University of Wisconsin, USA
SARS-CoV and other emerging coronaviruses
Prof. Ralph Baric University of North Carolina at Chapel Hill, USA
Vaccine adjuvants 1
Dr. Derek O'Hagan GSK Vaccine Research, USA